Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,2313399,Anxrr28,Anxiety related response QTL 28,,,aggression-related behavior trait (VT:0015014),tameness/aggressiveness composite score (CMO:0002136),6,104381930,138066274,Rat,n/a,region,qtl 1000,1331799,Bp211,Blood pressure QTL 211,3.66407,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),6,75623277,136426962,Rat,n/a,region,qtl 1000,1641917,Colcr5,Colorectal carcinoma resistance QTL 5,3.18,0.0009,intestine integrity trait (VT:0010554),benign colorectal tumor number (CMO:0001795),6,127286494,144745573,Rat,n/a,region,qtl 1000,61329,Eae9,Experimental allergic encephalomyelitis QTL 9,3.7,,body mass (VT:0001259),change in body weight (CMO:0002045),6,127286494,147991367,Rat,n/a,region,qtl 1000,1300076,Glom8,Glomerulus QTL 8,7,0.000000009,kidney glomerulus morphology trait (VT:0005325),count of superficial glomeruli directly contacting the kidney surface (CMO:0001001),6,91703409,136703409,Rat,n/a,region,qtl 1000,2293085,Iddm29,Insulin dependent diabetes mellitus QTL 29,7.66,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),6,127286494,147249902,Rat,n/a,region,qtl 1000,71111,Iddm8,Insulin dependent diabetes mellitus QTL 8,1.9,0.002,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),6,132652096,138068606,Rat,n/a,region,qtl 1000,4145118,Mcs26,Mammary carcinoma susceptibility QTL 26,,0.0001,mammary gland integrity trait (VT:0010552),post-insult time to mammary tumor formation (CMO:0000345),6,111134524,138065254,Rat,n/a,region,qtl 1000,737976,Pia24,Pristane induced arthritis QTL 24,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),6,117355600,147991367,Rat,n/a,region,qtl 1000,61414,Pia3,Pristane induced arthritis QTL 3,4.5,,joint integrity trait (VT:0010548),post-insult time to onset of experimental arthritis (CMO:0001450),6,99273921,144792678,Rat,n/a,region,qtl 1000,2312560,Pur20,Proteinuria QTL 20,2.1,0.005,total urine protein amount (VT:0000032),urine total protein excretion rate (CMO:0000756),6,130561943,144745573,Rat,n/a,region,qtl 1000,12801411,Schws8,Schwannoma susceptibility QTL 8,,,nervous system integrity trait (VT:0010566),percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017),6,99273921,144273921,Rat,n/a,region,qtl 1000,1358355,Srcrt4,Stress Responsive Cort QTL 4,6.39,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),6,104363890,147991367,Rat,n/a,region,qtl 1000,724513,Uae14,Urinary albumin excretion QTL 14,6.5,,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),6,88996335,139410483,Rat,n/a,region,qtl 1000,731173,Uae22,Urinary albumin excretion QTL 22,10.1,,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),6,68781170,147991367,Rat,n/a,region,qtl 1000,2290393,Uae37,Urinary albumin excretion QTL 37,,0.0001,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),6,68781170,147991367,Rat,n/a,region,qtl 1000,2303624,Vencon5,Ventilatory control QTL 5,4.45,,respiration trait (VT:0001943),minute ventilation (VE) (CMO:0000132),6,92879510,137879510,Rat,n/a,region,qtl 1000,8552796,Vie3,Viral induced encephalitis QTL 3,2.6,,brain integrity trait (VT:0010579),encephalitis incidence/prevalence measurement (CMO:0002361),6,101207574,147991367,Rat,n/a,region,qtl